Slide 1: Cancer Genetics & Professional Laboratory Services
Cancer Genetics & Professional Laboratory Services Jon Cohen, MD Senior Vice President and Group Executive Diagnostic Solutions, Chief Medical Officer November 5th, 2014
Slide 2: Safe Harbor Disclosure
| 2 Safe Harbor Disclosure The statements in this presentation which are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management’s current
Slide 3: Cancer Genetics: Assessing Risk and Guiding Treatment
| 3 Cancer Genetics Assessing Risk Breast & Ovarian Colorectal & Endometrial BRCAvantage™ Guiding Treatment Solid Tumor Leukemia OncoVantage™
Slide 4: BRCAvantage: Assessing Risk of Breast and Ovarian Cancer
| 4 BRCAvantage™: Assessing Risk of Breast and Ovarian Cancer Market Overview and Trends 940,000 people in the US carry the BRCA gene 2.3M at high risk and should be screened $3B market
Slide 5: BRCAvantage: Insights and Services
| 5 BRCAvantage™: Insights and Services Concierge & Preauthorization Services Women’s Health, Primary Care, Hospital, and Oncology Sales Teams BRCAvantage™ Plus 7 Gene Expanded Breast Cancer Panel Specialized Medical Oncology Sales Team Patient Awareness Advocacy Financial Assistance Genetic Counsel
Slide 6: OncoVantage: Guiding Cancer Treatment
| 6 OncoVantage™: Guiding Cancer Treatment Market Overview and Trends 1.6M new cancer cases each year 1.2M estimated patients with failed therapy $1.3B is underpenetrated approximately
Slide 7: OncoVantage: Memorial Sloan Kettering and Quest Partnership
| 7 OncoVantage™ Guiding Treatment Memorial Sloan Kettering Cancer Center and Quest Diagnostics Partner to Advance Precision Medicine in Cancer Diagnosis and Treatment Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance res
Slide 8: Professional Lab Services
Professional Lab Services | 8
Slide 9: Hospital and Hospital System Business Solutions
| 9 Hospital and Hospital System Business Solutions Level of Strategic Partnership Reference Testing Options Managed Labs Options V alue C re atio n Outreach Solutions Population Management Utilization Management Improve Inpatient Experience Clinical Franchise Solutions Increase Patient Stickiness R
Slide 10: PLS Strategic Relationships
| 10 PLS Strategic Relationships Client State Number of Hospitals Number of Beds Safety Net Illinois 1 125 Rural New York 1 100 Community Connecticut 1 200 Health System Alabama 4 956 Community Pennsylvania 1 200 Health System New Jersey 4 1250 A Track Record of Success
Slide 11: Key Takeaways
| 11 Key Takeaways Aggressively pursuing the growing market for cancer genetics Successfully launched and enhanced BRCAvantage solution Partnered with world’s premier cancer institution to reach community oncologists Leveraging Quest assets to deepen relationships with hospital clients New professio